Up-regulation of PKM2 promote malignancy and related to adverse prognostic risk factor in human gallbladder cancer

作者：Lu, Wei; Cao, Yang; Zhang, Yijian; Li, Sheng; Gao, Jian; Wang, Xu-An; Mu, Jiasheng; Hu, Yun-Ping; Jiang, Lin; Dong, Ping; Gong, Wei; Liu, Yingbin^*

来源：Scientific Reports, 2016, 6(1): 26351.

DOI：10.1038/srep26351

• SQUAMOUS-CELL CARCINOMA
• PYRUVATE-KINASE M2
• TYROSINE PHOSPHORYLATION
• EXPRESSION
• STANDARDIZATION
• MANAGEMENT
• GROWTH
• GENE

Recently, pyruvate kinase M2 (PKM2) has been implicated in the progression of certain cancers and might play pivotal roles in the formation of malignancy. However, the role of PKM2 in gallbladder cancer had not been well investigated. This study analyzed associations between PKM2 expression status with various clinical and pathologic parameters in a large cohort of gallbladder cancer (GBC) patients from a long term follow up results. The expression level of pyruvate kinase isotypes in GBC tissues and their adjacent normal gallbladder tissues were estimated by qRT-PCR and Western blot. PKM2 mRNA level were significantly high in gallbladder cancer tissues than in adjacent noncancerous tissues (P < 0.001). High expression of the PKM2 was detected in 55.71% paraffin-embedded GBC tissue. The high PKM2 expression was independently associated with poorer overall survival in patients with GBC (median survival 11.9 vs 30.1 months; hazard ratio 2.79; 95% CI=1.18 to 6.55; P=0.02). These findings indicated elevated expression of PKM2 is a prognostic factor for poor GBC clinical outcomes, implied involving of PKM2 in GBC progression.

• 出版日期2016-6-10
• 单位大连医科大学; 上海交通大学; 复旦大学